Edward M. Kaye M.D., Director at CYTOKINETICS INC (CYTK), sold 13,390 shares at $55.08 ($738K) on 2025-09-30, disclosed to the SEC on 2025-09-30.
Scheduled sale ($738k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.08 | 6,695 | $369K | 50.0% |
| 2 | $55.08 | 6,695 | $369K | 50.0% |
| Total | $55.08 avg | 13,390 | $738K | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |